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Abstract
Detailed information about stage-specific changes in gene expression is crucial for understanding the gene regulatory
networks underlying development and the various signal transduction pathways contributing to morphogenesis. Here we
describe the global gene expression dynamics during early murine limb development, when cartilage, tendons, muscle,
joints, vasculature and nerves are specified and the musculoskeletal system of limbs is established. We used whole-genome
microarrays to identify genes with differential expression at 5 stages of limb development (E9.5 to 13.5), during fore- and
hind-limb patterning. We found that the onset of limb formation is characterized by an up-regulation of transcription
factors, which is followed by a massive activation of genes during E10.5 and E11.5 which levels off at later time points.
Among the 3520 genes identified as significantly up-regulated in the limb, we find ,30% to be novel, dramatically
expanding the repertoire of candidate genes likely to function in the limb. Hierarchical and stage-specific clustering
identified expression profiles that are likely to correlate with functional programs during limb development and further
characterization of these transcripts will provide new insights into specific tissue patterning processes. Here, we provide for
the first time a comprehensive analysis of developmentally regulated genes during murine limb development, and provide
some novel insights into the expression dynamics governing limb morphogenesis.
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Introduction
The developing limb serves as an ideal model for studying
differentiation of pluripotent mesenchymal cells into several
distinct tissues, including cartilage, muscle, blood vessels, tendons
and endochondral bone [1]. While the limb is a well established
model system for studying genetic factors that regulate tissue
patterning, differentiation and growth, the last decade of limb
development research has been dominated by the same collection
of widely studied genes, with little introduction of new candidate
contributors. However, malformations affecting the limbs, more
specifically the number of digits with which an infant is born, are
among the most frequent congenital defects recorded in humans,
occurring as often as 1 in 1000 live births. Currently, there are
about 221 syndromes described with polydactyly and 120
syndromes with oligodactyly [2]. Despite this wide prevalence of
limb abnormalities, to date only ,84 genes have been associated
with syndromes that include limb defects, 15 of which have
described polydactyly [2]. Similarly, the sequential and tightly
interconnected cellular events that lead to the establishment of
each individual tissue type, as well as the three-dimensional
molecular interplay within the vertebrate limb are not yet fully
understood [3]. Finally, we have yet to grasp how the genome
specifies fore- and hind-limb patterning to establish limb identity
and ultimately result in the formation of complex homologous
structures that are distinct in shape and function, such as the
human hand and foot [4,5].
The availability of DNA microarray technologies has provided
the opportunity to comprehensively examine gene expression in
serially homologous structures, such as the developing limbs. In
this study, we took a genome-wide transcript analysis approach to
obtain insights into the temporal and spatial pattern of gene
expression during limb formation from embryonic day 9 (E9.5;
shortly after limb bud initiates) to E13.5 when the cartilage
template of future bone formation is established, to determine
previously unidentified transcripts likely to contribute to limb
patterning and limb identity, as well as to describe cohorts of genes
that share the same stage-specific clustering, onset or peak
expression profiles and are likely to contribute to shared
developmental functions. Studies in Drosophila have determined
that periods of rapid morphological changes during embryogenesis
are associated with large-scale gene expression changes and have
suggested that cataloging tissue specific gene expression at various
stages of development would improve our understanding of factors
involved in the development and function of each tissue [6,7],
therefore, our study aimed to gain novel insights into the
molecular events underlying limb development.
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has been acquired by observing the normal development of
chicken embryos, in ovo; by ectopically administering molecules to
the chicken limb and documenting the resulting morphological
changes; or more recently, through the characterization of mutant
mice with limb defects [8]. Forelimb buds start first, as small
bilateral protrusions near the anterior end of the torso. About half
a day later, when the forelimb is already visible as a tissue bulge,
the hindlimb buds begin to protrude near the posterior end of the
embryo. Each limb bud is composed of lateral plate mesoderm
(LPM) covered by the surface ectoderm. The mesoderm contains
the progenitors of skeletal elements, tendons, and other connective
tissue of the fully-formed limb. The surface ectoderm gives rise to
the skin and other cutaneous structures such as feathers on birds or
hair on mammals. Shortly after the limb buds emerge, changes in
cell shape and position within the surface ectoderm result in the
appearance of a ridge, the apical ectodermal ridge (AER), which
runs along the distal margin of each limb bud. Immediately after
the AER has formed, a second control region emerges in the
posterior region of the limb bud, the zone of polarizing activity
(ZPA). The interplay between the AER, ZPA, ectoderm and the
underlying mesenchyme control the elongation along the proxi-
mo-distal axis (shoulder to fingers), the flattening along the dorso-
ventral axis (back of hand to palm), the number, and the identity of
digits along the antero-posterior axis (thumb to little finger).
In an effort to learn more about the genes involved in limb
morphogenesis, we have determined the global gene expression
profiles in a time course from limb initiation, at embryonic day 9.5
to E13.5 when the limbs are fully patterned. This study identified
3520 genes up-regulated in the mouse limb that comprise 20
distinct expression profiles and determined that more than 1000 of
these transcripts are novel, or have not yet been characterized in
the limb, dramatically expanding the repertoire of candidate genes
likely to function during limb pattering and development.
Results
Transcriptome Analysis Identifies 3520 Genes
Up-regulated in the Developing Mouse Limb
To identify novel molecules responsible for limb patterning
processes and determinants of limb identity, as well as to
characterize the expression profiles of genes co-transcribed at
high levels during limb development, we generated mouse whole-
genome microarray gene expression data for fore- and hind-limbs
from five consecutive developmental time points, from E9.5 to
E13.5 (Figure 1), accompanied by data for whole embryos as
controls. Fore- and hind-limb samples were compared to whole
embryo samples at each time point to determine which transcripts
were differentially expressed in the limb. Comprehensively, 6216
unique genes (31.4% of the mouse genome) were differentially
expressed in at least one of the comparisons (with 3520 being
significantly up-regulated), therefore, unless specified all percent-
ages herein are based on this total count of differentially expressed
genes (6216). We found E10.5–E11.5 to have the largest number
of significantly up-regulated genes, with 30–36% of the transcripts
up-regulated (1840–2263 genes). The least number of differentially
expressed genes was found in the E9.5 fore-limb, where only 8% of
the genes were up-regulated (Table 1), consistent with the very
early stage.
For the top 100 forelimb genes significantly up-regulated at
each developmental time point we examined the known molecular
function (GO category), description of available knock-out mouse
phenotypes (http://www.informatics.jax.org/phenotypes.shtml)
and the documented limb expression in whole mount mouse
embryos (http://genome.ucsc.edu/cgi-bin/hgVisiGene). Most
genes were represented in more than one developmental stage,
corresponding to a total set of 279 non-redundant transcripts
(Table S1). Thirty genes were up-regulated at all 5 time points,
126 were up-regulated at 4 time points (primarily E10.5–E13.5),
51 were up-regulated at 3 time points, 28 were up-regulated at 2
time points, and 44 transcripts were up-regulated at only one time
point, either E9.5 (28 genes) or E13.5 (16 genes).
Among the 279 transcripts significantly up-regulated in at least
one developmental stage, we found 21% to be transcription
factors, 10% signaling molecules, 9% membrane-associated
proteins (including receptors and channels) and 24% of them to
be of unknown or novel function. Twenty-eight percent of these
transcripts had confirmed musculoskeletal knockout phenotypes
(79 genes; highlighted in brown in Table S1), and a similar
percentage (27%; 76 genes) have been previously shown to be
expressed in the limb by in situ hybridization (Figure 2A). These
two sets of genes were highly overlapping (67%), and 23 genes with
confirmed limb expression patterns corresponded either to
previously uncharacterized genes, genes that resulted in no
phenotypes (normal mice) when knocked out from the mouse
genome, or the available knockout had no reported limb or
musculoskeletal defect. Of the genes previously uncharacterized in
the limb, 12 were perinatal lethal prior to E11.5 (highlighted in
purple in Table S1), 14 had in situ expression patterns available
and 137 or ,50% were novel, lacking any prior knowledge of
their putative limb function (Table S1; highlighted in grey). In
contrast, the available knockout mice for 38 genes had ‘normal’ or
no reported limb/musculoskeletal defects described, suggesting
that these genes may be functionally redundant and the loss of
their proteins is compensated by the presence of another, closely
related transcript. Table S1 provides details for all the 279
transcripts. When analyzing the putative gene function off all 279
limb-enriched genes, the largest number of transcription factors
(33%) and growth factors (15%) were found enriched at E9.5. In
addition, 45 of the total 77 genes with reported limb or
musculoskeletal defects in the documented knockout mouse strains
were up-regulated at E9.5 suggesting that limb morphogenesis
may be driven by very early signaling/transcriptional events that
commence immediately after limb bud initiation.
More than 100 Novel Genes are likely to Contribute to
Limb Morphogenesis
Among the 279 transcripts identified as the most highly
expressed genes in the murine limb relative to the whole embryo,
about half were novel (49% or 137 genes; Table S1; highlighted in
grey). We defined novel genes as genes with no available knockout
information and no published reports that would suggest the gene
is essential to limb patterning or function. A few of the novel genes,
primarily transcription factors, had known embryonic in situs
patterns and those were noted in Table 2. We surveyed in situ
expression patterns among 3 groups of transcripts: 1) genes known
to function during limb development (Figure S1), 2) known genes
previously uncharacterized in the limb (Figure 2B), and 3) novel
genes (Table S1; highlighted in grey and Figure 2C), and found
that while the majority of genes appeared to be expressed at E10.5
throughout the limb bud (without differentiating between
superficial ectodermal staining and mesenchymal deep staining),
a large number of genes had restricted and unique limb expression
patterns. For example, among the novel genes, C130021l20Rik was
expressed in dorsal ectoderm, Nnat and Cap1 were primarily
expressed in distal mesenchyme, Fibin was expressed at the base of
the limb corresponding to cells migrating from the somites into the
Limb Microarray Analysis
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The novel genes in Figure 2C are highlighted in grey in Table S1.
In particular, the transcript corresponding to the novel gene
C130021I20Rik, which was one of the most highly enriched
transcript [classified among the top 100 genes at all developmental
stages examined (E9.5 to E13.5)], was found to have a highly
restricted expression pattern, primarily in the dorsal mesenchyme,
highly similar to LIM homeodomain transcription factor 1 beta
(Lmx1b) [9] (Figure 2C). Further examination of the genomic locus
of this transcript, revealed that in the mouse, its transcription start
site is physically located 682 base pairs upstream of Lmx1B, and is
transcribed on the opposite strand (Figure 3A). Using nucleotide
blast we compared the Lmx1B 1.2 kb mRNA (NM_010725) to the
C130021I20Rik mRNA (AK147796) and found no significant
sequence homology between the transcripts. We also did a detailed
in situ analysis of these two genes from E10.5 to E12.5 (Figure 3B–
C) and found them to have highly similar expression patterns in
the limb. The close proximity of these genes, the lack of sequence
homology shared by the transcripts and the divergent transcrip-
tional direction of these two genes suggest that they are transcribed
from a bidirectional promoter and are likely to share cis-regulatory
elements that may be required for their shared limb-specific
expression patterns. LMX1B mutations in humans cause an
autosomal dominant inherited disease called nail-patella syndrome
(NPS), which is characterized by abnormalities of the arms and
legs as well as kidney disease and glaucoma [10,11]. Expression of
Lmx1b has been described as dorso-mesenchymal and this gene has
been shown to be critical for specification of dorsal limb cell fates
and consequently dorso-ventral patterning of limbs [12].
C130021I20Rik also appears to be restricted to the dorsal
mesenchyme (Figure 3B), suggesting that this new transcript may
functionally cooperate with Lmx1b to play a central role in fate
determination and/or cell differentiation in the dorsal limb.
Limits of Transcriptome Analysis: Missing Functional
Genes with Low Limb Expression
To identify transcripts with elevated levels of expression in the
limb we initially compared each limb sample to its corresponding
Figure 1. Limb Bud Morphology. Fore- and hind-limb buds were cut away from the embryo body as indicated by the red dash and RNA was
processed from the full appendages outlined for stages E9.5 to E13.5. Light blue indicate mesenchymal condensations, and cartilage as determined
by alcian blue staining is marked by thick black lines. Hindlimbs are morphologically delayed by ,half a day.
doi:10.1371/journal.pone.0028358.g001
Table 1. Differentially Expressed Genes.
Differentially Expressed Genes from Limb vs. Whole Embryo Comparisons
FL 9.5 HL 10.5 FL 10.5 HL 11.5 FL 11.5 HL 12.5 FL 12.5 HL 13.5 FL 13.5
Up-regulated 468 (8%) 1840 (30%) 1931 (31%) 2228 (36%) 2263 (36%) 1230 (20%) 1512 (24%) 1077 (17%) 953 (15%)
Down-regulated 347 (6%) 816 (13%) 796 (13%) 960 (15%) 868 (14%) 1194 (19%) 1189 (19%) 1799 (29%) 1765 (28%)
Up-regulated Genes differeing between Successive Limb Stage Comparisons
E9.5 vs E10.5 E10.5 vs E11.5 E11.5 vs E12.5 E12.5 vs E13.5
Forelimb 212 (3%) 1675 (27%) 328 (5%) 660 (11%) 1066 (17%) 315 (5%) 816 (13%) 257 (4%)
Hindlimb n/a n/a 283 (5%) 671 (11%) 1193 (19%) 195 (3%) 506 (8%) 353 (6%)
Stage-specific Up-regulated Genes
E9.5 E10.5 E11.5 E12.5 E13.5
Forelimb 186 (3%) 190 (3%) 405 (7%) 159 (3%) 200 (3%)
Hindlimb n/a 241 (4%) 473 (8%) 87 (1%) 259 (4%)
A total of 6216 or 31.4% of gene symbols represented on the Affymetrix mouse array displayed expression changes in at least one pairwise comparison. All percentages
displayed here are based on this total 6216 gene count. For both forelimbs (FL) and hindlimbs (HL) at each time point the number of up-regulated (.2X) and down-
regulated (,2X) genes in relationship to whole embryo total RNA levels are indicated. Gene cohorts relevant to particular developmental stages were determined by
comparing up-regulated genes between pairs of successive time points; genes exclusively up-regulated at each of the two time points considered (i.e., down-regulated
or unchanged at the other) are indicated for each comparison (E9.5 vs E10.5; E10.5 vs E11.5; E11.5 vs E12.5 and E12.5 vs E13.5). Genes up-regulated only at one particular
time point were identified by comparing the genes up-regulated at a given limb stage with those up-regulated at any other stage.
doi:10.1371/journal.pone.0028358.t001
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28358Figure 2. Analysis of the Top 100 Up-regulated Genes. 279 genes were examined for their putative protein function, available in situ
expression in the limb, and description of null mouse phenotype (A). Most known genes previously uncharacterized in the limb with (B), or novel
genes (C) showed unique and restrictive expression pattern in the limb. A survey of in situs of known genes with musculoskeletal defects in the
knockout mouse are in Figure S1.
doi:10.1371/journal.pone.0028358.g002
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Genes GO Category Ontology Description of GO Category p-value Enrichment
cluster 1 (44
genes)
4 47 GO:0048704 BP embryonic skeletal system morphogenesis 0.0002 36.83
19 682 GO:0003700 MF sequence-specific DNA binding transcription
factor activity
0.0000 12.06
3 114 GO:0045892 BP negative regulation of transcription, DNA-
dependent
0.0259 11.39
8 406 GO:0045944 BP positive regulation of transcription from RNA
polymerase II promoter
0.0001 8.53
4 211 GO:0016564 MF transcription repressor activity 0.0187 8.20
18 1499 GO:0003677 MF DNA binding 0.0000 5.20
cluster 2 (51
genes)
2 6 GO:0070700 MF BMP receptor binding 0.0056 124.44
2 6 GO:0060272 BP embryonic skeletal joint morphogenesis 0.0056 124.44
4 33 GO:0001649 BP osteoblast differentiation 0.0008 45.25
3 28 GO:0030855 BP epithelial cell differentiation 0.0033 40.00
4 42 GO:0030509 BP BMP signaling pathway 0.0014 35.56
4 55 GO:0030326 BP embryonic limb morphogenesis 0.0022 27.15
5 144 GO:0007507 BP heart development 0.0029 12.96
7 211 GO:0016564 MF transcription repressor activity 0.0008 12.39





4 33 GO:0048706 BP embryonic skeletal system development 0.0425 12.54
5 47 GO:0048704 BP embryonic skeletal system morphogenesis 0.0194 11.01
6 99 GO:0004888 MF transmembrane receptor activity 0.0471 6.27
6 101 GO:0009952 BP anterior/posterior pattern formation 0.0473 6.15
18 488 GO:0043565 MF sequence-specific DNA binding 0.0008 3.82
10 274 GO:0045941 BP positive regulation of transcription 0.0425 3.78
cluster 6 (475
genes)
4 8 GO:0048699 BP generation of neurons 0.0186 20.52
5 22 GO:0035108 BP limb morphogenesis 0.0405 9.33
7 38 GO:0042733 BP embryonic digit morphogenesis 0.0150 7.56
7 45 GO:0060021 BP palate development 0.0279 6.38
11 103 GO:0003735 MF structural constituent of ribosome 0.0150 4.38
10 100 GO:0006414 BP translational elongation 0.0351 4.10
20 242 GO:0006397 BP mRNA processing 0.0037 3.39
17 236 GO:0008380 BP RNA splicing 0.0186 2.96
cluster 7 (73
genes)
3 18 GO:0001837 BP epithelial to mesenchymal transition 0.0288 45.33
cluster 11 (405
genes)
4 6 GO:0042273 BP ribosomal large subunit biogenesis 0.0057 31.58
29 100 GO:0006414 BP translational elongation 0.0000 13.74
21 103 GO:0003735 MF structural constituent of ribosome 0.0000 9.66
19 214 GO:0006412 BP translation 0.0001 4.21
cluster 12 (491
genes)
5 17 GO:0070491 MF repressing transcription factor binding 0.0373 11.43
8 56 GO:0016566 MF specific transcriptional repressor activity 0.0373 5.55
21 261 GO:0000122 BP negative regulation of transcription from RNA
polymerase II promoter
0.0058 3.13
16 209 GO:0016481 BP negative regulation of transcription 0.0373 2.97
16 211 GO:0016564 MF transcription repressor activity 0.0373 2.95
18 262 GO:0051301 BP cell division 0.0437 2.67
29 468 GO:0015031 BP protein transport 0.0112 2.41
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expressed in the limb but at relatively low levels in all other parts of
the embryo will emerge as ‘up-regulated’ in the limb. Even if a
gene is expressed at high levels in other parts of the embryo, it will
still be identified as ‘up-regulated’ in the limb as long as its overall
RNA concentration (total RNA per sample volume) remains lower
in the whole embryo as compared to the limb sample. In contrast,
a gene that is ‘ubiquitously’ expressed will have similar RNA
concentrations and hence will not be identified as ‘up-regulated in
the limb. Thus, one potential limitation of this analysis stems from
comparing the limb expression to the whole embryo expression;
while powerful at extracting genes that are robustly expressed in
the limb in relationship to other tissues, it falsely eliminates
transcripts that are expressed in the limb at very low levels, or play
important roles in non-limb tissues and are thus highly expressed
in other parts of the embryo as well.
To estimate the rate of false negatives we examined how many
genes known to cause limb defects are up-regulated in our
comparisons. We extracted from the Mouse Genome Informatics
Database (http://www.informatics.jax.org/) all the genes (674
genes) annotated with abnormal limb morphology (MP:0002109)
as well as categories directly related to this one in the Phenotype
Ontology hierarchy. Of these 674 genes, only 449 were
represented on the array and 186 (41%) were significantly up-
regulated in the limb in at least one comparison. Next we
examined whether the genes that were not significantly up-
regulated had different expression levels in the limb and in the
whole embryo as compared with the genes up-regulated in the
limb. We found that the genes that were not up-regulated in limb
were expressed at significantly lower levels in the limb (P-
value=0.4610
213, Wilcoxon rank sum test), but at approximately
the same levels in the whole embryo. Furthermore, these genes
were found to be expressed at lower levels in the limb as compared
with all the genes on the array (P-value 2.9610
26, Wilcoxon rank
sum test), but not in the whole embryo. This analysis suggests that
it is the particularly low level of expression of these genes in the
limb rather than the differences in their average level of expression
in the whole embryo that reduces our power to detect them in the
context of this analysis (Figure S2).
We also examined 200 genes corresponding to the BMP, WNT,
TGF-beta, hedgehog, FGF, and ROR signaling pathways,
homeobox transcription factors along with other known signaling
molecules and transcription factors linked to these pathways. We
found 40% of these genes to be up-regulated in the limb in at least
one comparison (82/200; Table S2). Twenty-nine percent (58) of
these transcripts were down-regulated in the limb, compared to
whole embryos, at least at one time point, and unchanged at all





Genes GO Category Ontology Description of GO Category p-value Enrichment
cluster 14 (151
genes)
5 49 GO:0051216 BP cartilage development 0.0224 12.95
8/15 clusters were identified to contain cohorts of functional related genes (p,0.05; .2-fold enrichment) primarily represented by transcription factors (clustes 1/2/5/
12) and genes associated with limb/skeletal morphogenesis (clusters 1/2/5/6). ‘Gene count’ represents the number of genes in the cluster with the specified biological
process or molecular function, while ‘total # genes’ represents the total number of genes present on the microarray within the same category. Enrichment is fold over
background. Genes corresponding to GO enriched categories highlighted in brown are plotted in Figure 5. BP biological process; MF molecular function.
doi:10.1371/journal.pone.0028358.t002
Table 2. Cont.
Figure 3. C130021I20Rik is a Novel Gene Co-transcribed from the Lmx1b Promoter, a well Known Limb Gene. C130021I20Rik was
mapped to the Lmx1b gene locus (A) and found to be transcribed on the opposite strand. Time course in situ analysis revealed that C130021I20Rik (C)
expression pattern is indistinguishable from its neighbor, Lmx1b (B), in the dorsal mesenchyme (b–c) suggesting that they are transcribed from the
same divergent promoter and share limb-specific regulatory elements.
doi:10.1371/journal.pone.0028358.g003
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expression observed in the limb. An additional 6 transcripts
displayed a mixture of up-regulated and down-regulated incidenc-
es at specific time points, mostly in the Hox transcription factor
category (4/6 genes). Most of the hedgehog signaling pathway
genes were underrepresented among the up-regulated genes (Gli2;
1/7 was enriched in the limb), primarily because of their wide
tissue distribution that masked their transcriptional enrichment in
the limb.
Finally, we examined the expression values for genes transcribed
at low, moderate and high levels in the limb. Genes on the arrays
had (log2 transformed) expression values ranging from 2.4 to 14.6,
with a median of 6.1. Using the average expression values for Lrp5
and Shh, genes known to have important roles in the limb, but
expressed at low levels (Lrp5; 4.2–5.6 expression value range) or in
a highly restricted cluster of cells (Shh; 4.7–8.8 expression value
range), we identified 19 genes with low expression values (,5) at
all 5 developmental time points. This list included 4 genes known
to have limb defects as heterozygous or homozygous null (Tbx6/
Tbx22/HoxB13/Lmx1a). These analyses suggest that up to 60% of
genes of limb genes expressed at very low levels may be missed by
this method (Table S2; genes highlighted in yellow). However,
additional biological validation will be needed to confirm the true
rate of false negatives.
Shared Expression Profiles Reveal Gene Specific
Functions in Limb Development
Genes significantly up-regulated in the forelimb clustered into
31 groups according to their expression profiles. Twenty of these
groups were comprised primarily of the up-regulated expression
profiles of 3213 transcripts or 91% of the total genes found to be
up-regulated in at least one pair-wise comparison with the
corresponding whole embryo control. These 20 clusters were
further grouped into four major categories: early genes, peak
genes, late genes and oscillating genes (Figure 4A–D; genes
corresponding to each cluster are listed in Table S3). The
expression of 247 transcripts was elevated at E9.5 and at least one
other time point, as part of clusters 1–4 comprising the ‘early gene’
category, where only 44 transcripts were enriched at all examined
time points (Figure 4A).
A second category of genes, defined as ‘peak genes’, were
distinctly up-regulated either at a single time point or within a
narrow range of time points (Figure 4B). The largest cluster
consisted of transcripts up-regulated at E10.5 and E11.5 (491). A
smaller cluster encompassed genes enriched between E10.5 and
E12.5 (401) and 151 transcripts were significantly up-regulated at
E11.5 and E12.5. Genes that peaked at a single time point were
classified as ‘stage-specific’ genes and are discussed in the next
section. A third category of genes, termed ‘late genes’ turned on past
E9.5 and their up-regulated expression persisted up to E13.5, and
possibly beyond. A large number of transcripts (475) were found
significantly up-regulated from E10.5 to E13.5, while smaller
cohorts were enriched from E11.5 (73) or E12.5 (77) and beyond.
The last category of genes, ‘oscillating genes’ is represented by
clusters of genes that display patterns of oscillating up-regulation in
the limb, relative to whole embryo. A small number of genes (151)
were distributed among these 5 clusters, with the smallest clusters
representing genes that are up-regulated only at E9.5 and E11.5
(22), or at E10.5 and E13.5 (20). To determine if these genes truly
Figure 4. Temporal Expression Pattern Analysis in the Developing Forelimb. Clusters of co-transcribed genes were grouped into early
genes (A), peak genes (B), late genes (C) and oscillating genes (D) based on their profiles. The number of genes corresponding to each curve are
indicated below the trace.
doi:10.1371/journal.pone.0028358.g004
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misleadingly derived because of fluctuating expression levels in
the whole embryo we normalized the log2 expression value of each
gene so that the mean and standard deviation across all the arrays
are 0 and 1 respectively and plotted the limb and whole embryo
expression in Figure S3. For most whole embryo samples we found
the log2 expression to be negative, corresponding to low level of
expression in the whole embryo. In most cases we found that,
indeed, the limb expression oscillates, but the oscillating behavior
was due either to variability in the limb expression only, or both in
the limb and whole embryo (Figure S3). For example, in the case
of genes that are ‘‘on’’ in the forelimb at E10.5 and E12.5 (51
genes), we actually have two effects at work: these genes are
particularly highly expressed in the limb at these time points, but
they are also slightly less expressed in the whole embryo as well,
magnifying this effect. Similar observations were made for genes
‘‘on’’ in the fore-limb at E10.5 and E13.5: their expression was
slightly decreased in the forelimb at E11.5 and E12.5, but also
slightly increased in the whole embryo. Although the observed
changes in expression are obviously not restricted to the limb,
there is a limb-specific trend in their expression and this trend in
the limbs is contrary to that in the whole embryo.
One goal of using cluster analysis for such comprehensive
expression datasets is to detect co-expressed genes, potentially
revealing gene networks likely to regulate functionally distinct
developmental processes such as chondrogenesis, osteoblastogen-
esis or myogenesis that progress concomitantly (Figure 5A). While
the limb has long been an important model system for examining
the molecular mechanisms of tissue patterning during develop-
ment, its tissue heterogeneity, with many different cell types and
signaling pathways intersecting to build complex multifunctional
structures, poses a great challenge for the identification of
functionally related genes. In Figure 5 we have outlined the
events, developmental landmarks, and few molecular markers
currently known for the formation of skeletal elements, muscle,
nerves and skin between E9.5 and E14.5. To determine whether
we can identify new gene candidates likely to contribute to one, or
more of these pathways, we examined all clusters with more than
40 transcripts (15 clusters) for the presence of enriched functional
categories (enrichment $2 fold with p-values adjusted for multiple
testing #0.05) using the available Gene Ontology (GO) annotation
for each transcript. ,50% of the clusters examined (8/15) were
found to be statistically enriched in genes that share a molecular
function or a biological process (Table 2).
Clusters 1, 2, 5, and 6 were found to be enriched in transcripts
involved in limb and skeletal morphogenesis, while clusters 1, 2, 5
and 12 were enriched in genes associated with transcriptional
regulatory functions. The transcripts in cluster 1 (44 transcripts)
were up-regulated in the limb at all examined time points; 45% of
them had documented limb and/or skeletal defects (20/44) and
40% corresponded to transcription factors (18/44), a 12-fold
enrichment for DNA binding transcription factor activity (Tables 2;
S3).
We plotted the relative expression levels for the genes
corresponding to osteoblast differentiation, epithelial differentia-
tion, anterior-porterior patterning, neuronal differentiation, digit
morphogenesis, epithelial-mesenchymal transition, cartilage de-
velopment, embryonic skeletal morphogenesis, and limb morpho-
genesis enriched categories in Figure 5B–J and examined their
expression dynamics vis-a `-vis what is known about the morpho-
logical events during this developmental time course (Figure 5A).
For most of these clusters we found a tight correlation between
their expression pattern and the function they are known to
participate in. For example anterior-posterior pattering is an early
event, therefore most of the genes associated with this function had
the highest expression level at E9.5, and continued to decline
beyond this time point (Figure 5D). In contrast, digit morphogen-
esis occurs beyond E10.5, and most transcripts associated with this
function were not expressed at E9.5, but were sharply up-
regulated at E10.5 and beyond (Figure 5F). The most surprising
observation was for genes associated with osteoblast differentiation
(Figure 5B). Osteoblasts themselves are not ‘present’ in the limb
until late E12.5, early E13.5, yet, these genes seemed to be
consistently expressed at high levels during most time points,
suggesting that these genes either participate in multiple
independent events during limb morphogenesis, or that osteoblast
specification and differentiation may initiate much earlier than
anticipated and new cell-type specific markers may be needed to
discriminate pre-osteoblasts from mature osteoblasts. While
functional correlation of genes comprising these clusters can only
be achieved through experimentation and validation, these new
relationships can assist prioritization in future functional charac-
terization of limb genes and conclusively link the genes with the
biological process they mediate during musculoskeletal morpho-
genesis.
Stage Specific Limb Development is Regulated by
Redundant Mechanisms
With the aim of identifying the genes that determine limb
patterning at particular developmental stages, we first established
differences among cohorts of up-regulated genes between all pairs
of successive time points. Overall, less than 27% of genes were
differentially expressed between consecutive time points, with most
changes ranging between 3–10% of the total 6216 differentially
expressed transcripts were limb specific. We found the most
dramatic up-regulation of gene expression to occur between E9.5
and E10.5 fore-limb comparisons, where ,8 times more
transcripts or 27% of total transcripts were more highly expressed
at E10.5 forelimb than at E9.5. In the hindlimb, a similar
transition was observed between E11.5 and E12.5 where the E11.5
hindlimb had 6 times more genes expressed than the E12.5
hindlimb. Since hindlimb development is delayed approximately
by half a day in relationship to fore-limb development [13], we
compared the overlap between E10.5 fore-limb specific genes
(1675) and E11.5 hind-limb specific genes (1193). We found 607
transcripts or 50% of genes to be shared among these two cohorts,
suggesting that E10.5 in forelimb and E11.5 in hindlimb may be
proceeding through similar morphological processes and may
represent key transitional time points during limb development,
with the greatest number of up-regulated transcripts during the
E9.5 to E13.5 developmental window.
Next, we turned to the analysis of strictly stage-specific genes,
i.e., genes that are exclusively up-regulated at one time point
(Figure 4B; stage specific genes). E11.5 had the largest number of
stage-specific transcripts (405 or 7%), E12.5 has the least (159 or
3%), while all other time points had an average of 192 genes (3%).
Twenty-three of these transcripts were also found among the top
100 overexpressed genes in the fore-limb, and are highlighted in
Table S1 by 1 or 3 asterisks. We examined the known molecular
function, description of available knock-out mouse phenotypes and
the documented limb expression in whole mount mouse embryos
for these 1121 genes (Table S4). E9.5 enriched transcripts had the
largest number of confirmed musculoskeletal null phenotypes (30/
184 or 16%), while E13.5 had the lowest (9/183 or 5%). The
reverse relationship was observed for genes without any reported
function in the limb, where 82% of the E13.5 enriched transcripts
(150/183) had no available knockout, nor was the gene ever linked
to any embryonic limb developmental function; in contrast 57% of
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(Figure 6A).
The in situ expression pattern survey of these 1121 stage specific
genes revealed that with the exception of E9.5 and E10.5 genes
where 18.5% and 11.5% were confirmed to be expressed in the
limb, all other time points had less than 7% of genes with reported
limb expression data. In Figure 6 we show the spatial expression
pattern for representative stage specific genes from each time point
(marked by an asterisk in Table S4). While a majority of these
transcripts appear to be expressed throughout the limb bud
(without differentiating between superficial ectodermal staining
and mesenchymal deep staining), a large number of these genes
also exhibit restricted and unique limb expression patterns.
Interestingly, even transcripts where the available knockout mouse
has not been reported to have a musculoskeletal defect show highly
restricted limb expression patterns. Such genes include Lmo1,
Lmo3, Irx2 and Irx5 transcription factors (Figure 6). While Lmo1
and Lmo3 knockouts have no obvious phenotypes, the Lmo1/Lmo3
double knockout dies shortly after birth due to neural tube defects.
In contrast Lmo2 and Lmo4 knockouts die embryonically before
E10.5, suggesting that some or all of the 4 Lmo family members
have redundant and overlapping functions, possibly including
aspects of limb development [14].
Several other gene families were overrepresented among these
stage specific enriched genes: 19 transcription factors belonged to
the Kruppel associated box (KRAB-containing zinc finger)
transcription factor family of transcriptional repressors (in
descending order of expression: E9.5 enriched Zfp771, Zfp775;
E10.5 enriched Zfp763, Zfp418, Zfp68; E11.5 enriched Zfp90,
Zfp783, Zfp13, Zfp637; E12.5 enriched Zfp57, Zfp354b, Zfp110,
Zfp324, Zfp715; and E13.5 enriched Zfp760, Zfp826, Zfp280d,
Zfp207, Zfp788); 11 genes belonged to the Tmem family of
transmembrane-like proteins (E9.5 enriched Tmem59l, Tmem115,
Tmem54, Tmem178, Tmem101; E10.5 Tmem177, Tmem2, Tmem120a
; E11.5 Tmem138; E12.5 Tmem208, Tmem11); 4 genes are
metallopeptidases as part of Adam and Adamts familes (E9.5
enriched Adamts18 and Adamts1; E10.5 Adam10; E11.5 Adamts7 and
E13.5 Adamts6); and 3 genes belonged to the SWI/SNF related,
matrix associated, actin dependent chromatin regulators or Smarc
genes (E9.5 SmarcD2; E11.5 SmarcD3 and SmarcE1).
Zinc finger proteins containing the KRAB motif represent the
largest single family of transcription factors, estimated to make up
,30% of all annotated zinc finger transcription factors in the
human genome (290/799) [15], therefore it is no surprise that
,2% of all the stage-specific enriched genes or 12% of the total
transcription factors belong to this category. What is unexpected,
however, is that only 2 of the 11 genes identified have been
previously studied; Zfp110 knockout has been described to be
perinatal lethal by E12.5, and Zfp826 has documented skeletal and
craniofacial defects [16]. Among the 91 transcription factors in this
category, 51 have available knockouts, 46 (90%) of which have
been described to exhibit various musculoskeletal/limb defects or
are perinatal lethal. The remaining 5 KOs are either normal or do
not have any reported limb defects (Table S4). This high
percentage of transcription factors with skeletal defects suggests
that most of the other 40 novel transcription factors in this
category are likely to participate in important events during limb
morphogenesis, particularly with a likely role during the narrow
developmental time point when their transcription is relatively up-
regulated.
Disintegrin and metalloproteinases (ADAM) and ADAMs with
thrombospondin motifs (ADAMTS) are two subfamilies of
metalloproteinases closely related to the matrix metalloproteinases
(MMPs). Some members of these subfamilies are associated with
various physiological and pathological processes involved in
embryonic development, angiogenesis, coagulation, and arthritis
[17]. Nineteen distinct ADAMTS genes have been identified in
humans, 4 (21%) of which are enriched in the limb. Their
substrates include procollagen, hyalectans, decorin, fibromodulin
and cartilage oligomeric matrix protein, hence based on their
previously characterized roles these 4 Adamts genes enriched
during limb development are likely to contribute to joint and
cartilage formation. Adamts1 knockout has a described adipose
tissue defect, while the function of all the other 3 (Adamts 6, 7 and
18) have not yet been examined in knockout mice. ADAM10, the
other metalloproteinase found to be up-regulated in the limb at
E10.5, causes embryonic lethality by E9.5 due to failure of the
cardiovascular and nervous system failures [18].
Hindlimb Identity is likely achieved by Inhibition of
Forelimb-Specific Genes
The analysis of differentially expressed genes is a powerful
approach for elucidating the genetic mechanisms underlying the
morphological and evolutionary diversity of serially homologous
structures within the same organism (hand vs. foot) or among
different species (hand vs. wing). Most genes known to be involved
in limb patterning processes have been shown to confirm highly
similar expression patterns in both the fore- and the hind-limb,
however they dictate the formation of skeletal elements that results
in distinctly unique structures such as hands and fingers in the
forelimb and feet and toes in the hindlimb. Despite these
dramatically different phenotypic skeletal patterning outputs, to
date only a few genes have been determined to regulate limb-type
identity. These include the forelimb-restricted Tbx5 and the
hindlimb-restricted Tbx4 and Pitx1 transcription factors
[19,20,21,22]. It has been hypothesized that additional key
regulators of limb identity exist. This hypothesis is based on
several observations: Pitx1, Tbx4 and Tbx5 are all transcription
factors however their target genes are not known, nor are the
upstream transcriptional regulators that confirm their limb
specificity. In addition, gain- and loss-of-function mutations in
these genes result in partial limb-type transformation phenotypes
suggesting that additional key molecules participate in limb-type
specificity.
To identify new genes and formulate new hypotheses about
initial patterning control and molecular pathways that dictate
limb-specific identity we compared fore- and hind-limb expression
at each time point (E10.5–E13.5, Figure 7A). Comprehensively,
Figure 5. Differentiation Events Corresponding to Stages of Limb Development and Functional Category Enrichments that
Describe some of these Events. Here we graphically depict the change in cell types and tissue formation as a function of developmental stage,
highlighting key events during bone, muscle, nerve and skin formation (A). Some key molecules known to participate in these processes are also
included along with the cell type morphologies for different stages of skeletal development. GO analysis identified several enrichment categories
including osteoblast differentiation (B), epithelial differentiation (C), anterior-posterior patterning (D), neuronal differentiation (E), digit
morphogenesis (F), epithelial to mesenchymal transition (G), cartilage development (H), embryonic skeletal system morphogenesis (I) and limb
morphogenesis (J). For each plot log2 intensity is on the y axis, and developmental stages are on the x-axis. For each gene the solid trace depicts limb
expression and the dashed trace depicts expression found in the whole embryo. Each gene corresponds to a different symbol along the traces.
doi:10.1371/journal.pone.0028358.g005
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fore- and 511 in the hind-limb, at least in one developmental time
point. 230 transcripts were enriched in the forelimb at E9.5, 155 at
E10.5, 245 at E11.5, 298 at E12.5 and 105 at E13.5. In the
hindlimb, we observed 278 enriched transcripts at E10.5, 151 at
E11.5, 36 at E12.5 and 114 at E13.5 (Figure 7B).
Figures 7C–D show genes up-regulated 2-fold or more in fore-
(76) or hind-limb (11), relative to each other, in at least one time
point. Furthermore, we examined the known molecular function,
description of available knock-out mouse phenotypes and the
documented limb expression pattern in whole mount mouse
embryos for these genes and found 37% of them to have
Figure 6. Analysis of Stage Specific Gene Expression. 1140 transcripts were found to be significantly up-regulated exclusively at one
developmental time point. A large fraction of these stage specific genes were found to be novel (A), in particular at E13.5 only 5% of the transcripts
had confirmed musculoskeletal knockout phenotypes and 6% of the genes have been validated by in situ hybridization. A survey of available in situ
expression profiles for genes with peak expression levels at E9.5 (B), E10.5 (C), E11.5 (D), E12.5 (E) and E13.5 (F) revealed that they display a wide range
of patterns, and include closely related members of gene families such as Irx, Smarc and zinc finger transcription factors.
doi:10.1371/journal.pone.0028358.g006
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11) in available knockout mice (Table S5). In addition, all genes
that have been previously shown to be differentially expressed
between fore- and hind-limbs, including Pitx1, Tbx4, Tbx5, and
several Hox genes were also found to be differentially expressed at
least at one sampled time point (Figure 7C–D; red arrows). The
identification of these genes provided a positive control, and these
differences were confirmed by whole mount in situ hybridization
(Figure 8). Among the genes for which we could evaluate a protein
function description based on GO classification confidence level
and available experimental data, we found 25% (19/76) of fore-
and 45% (5/11) of hind-limb genes to be known or putative
transcription factors, suggesting that limb identity may be driven
by a divergent transcriptional program, that uses different cohorts
of transcription factors to instruct limb identity.
Discussion
Limb Morphogenesis is orchestrated by .35% of a
Vertebrate Genome
This analysis provides a detailed description of the gene expression
dynamics during murine limb development from limb bud initiation at
E9.5 to a fully patterned autopod, at E13.5, and complements other
efforts that attempt to study individual genes and pathways during limb
morphogenesis through gene visualization (in situs) or targeted
mutagenesis. Our analysis identified 3520 transcripts that are highly
expressed in the limb and are likely to participate directly or indirectly
in various aspects of limb patterning, growth and tissue function,
dramatically increasing the repertoire of candidate genes that can be
systematically studied in reverse genetic analysis to identify novel
contributors to this intricate developmental process.
Figure 7. Identifying Genes that Contribute to Limb Identity. To identify genes specifically enriched in the forelimb or hindlimb, we adjusted
for the developmental delay of hindlimbs by comparing forelimbs to same stage hindlimbs as well as to hindlimbs from a subsequent time point (A).
More forelimb enriched genes were identified (B), and the genes with .2 fold up-regulation in the forelimb (C) or hindlimb (D) are displayed. Genes
previously known to function as a limb-identity determinant are marked by red arrows (Tbx5; Hoxc10, Tbx4, Pitx1).
doi:10.1371/journal.pone.0028358.g007
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the limb .2-fold relative to whole embryo, we recognized that one
potential limitation of our approach would be to falsely eliminate
important limb genes that are expressed at very low levels in the
limb, and do not meet these standards. To estimate the false
negative rate, we used the average expression values to carry out a
systematic survey of genes known to cause limb defects when
mutated in knockout mice, yet are endogenously expressed at very
levels in the limb. Our results estimate that up to 60% of these
genes may be missed by this method suggesting that the list of
genes in the limb may be much greater than the 3520 identified by
the microarray experiment described herein. Nonetheless, using
an estimate of 25000 total genes in the mouse genome, we can
estimate that about ,35% of a vertebrate genome participates in
aspects related to limb patterning and morphogenesis.
Identification of New Candidate Genes
In this manuscript, comprehensively, we have described ,1500
genes that are highly expressed in the limb, and we provide
detailed information about their known contribution to limb
development including the molecular function, description of
available knock-out mouse phenotypes and the documented limb
expression in whole mount mouse embryos along with relevant
citations. We find more than 30% of these genes to be novel or
have not yet been examined in the context of limb development,
and provide some new insights into expression dynamics and gene
cohorts that may contribute to unique aspects of limb morpho-
genesis. Particularly we focused on describing a cohort of 137
novel transcripts which represent a useful resource of new limb
candidates that can be further examined in the context of mutant
mice. We also find a large number of transcription factors (E9.5:
27/184 or ,15%; Table S4) to be specifically enriched during
limb initiation, in contrast to all other time points examined
(E10.5: 9.5%; E11.5: 5%; E12.5: 4.5%; 11%; Table S4), 30% of
which are novel (9/27; Table S4, highlighted in grey). These genes
are likely to be responsible for setting up cascades of gene
activation or repression, therefore further analysis of these cohorts
of genes will facilitate the dissection of gene regulatory networks
Figure 8. Expression Patterns of Fore- and Hind-limb Specific Genes. Qualitatively some genes identified as forelimb or hindlimb specific do
not appear to be restricted to one limb such as Sp6, SmarcD2 and Hoxc10, yet quantitatively these transcripts are .2 fold up-regulated in one limb in
relationship to the other.
doi:10.1371/journal.pone.0028358.g008
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proteomic approaches. It also represents a starting point for
interrogating parallel and overlapping gene networks that
contribute to the specification, formation and growth of different
tissues that comprise the developing limb and possibly be
applicable to other organs in the mammalian body.
Functional Redundancy during Limb Patterning
Similar to other published microarray reports, we too recognize
that there is significant functional redundancy among paralogous
and closely related genes in the limb. While one gene knockout
may not reveal a limb or musculoskeletal phenotype, there is a
high likelihood that closely related genes co-expressed in the limb
may compensate for each other and be deemed as modifiers of
limb development when analyzed in compound mutant allele
configurations. This is the case for several transcription factors,
such as Lhx2, Lhx9 (the most highly up-regulated gene at E9.5),
Prrx1 and Prrx2 which are all normal as single knockouts but Lhx2/
Lhx9 double knockouts display limb patterning and growth defects
along AP and PD axis and Prrx1/Prrx2 double knockouts exhibit
postaxial polydactyly and bent zeugopods (Table S1; References
S1). Similarly, genes for which the knockout phenotype is ‘normal’
or displays no limb/musculoskeletal abnormalities but the in situ
expression reveals a remarkably strong and specialized pattern as
in the case of Wif1, Figf, and Pknox1 (to name a few from the 38
transcripts found to have no limb knockout phenotypes), there is a
high likelihood that functionally related transcripts may be
compensating for the loss of these genes.
Genetic Pathways Responsible for Limb Identity
Recently it has been proposed that limb identity is achieved by
default in the forelimb, whereas Tbx4 propagates a unique
transcriptional program in the hindlimb through the systematic
repression of certain transcripts that may primarily function to
drive forelimb morphogenesis [23]. Our results are consistent with
this view since we observed ,7.5-fold less genes up-regulated in
the hindlimb and 45% of these hindlimb up-regulated genes are
transcription factors (Table S5). Since it is generally recognized
that the transcriptome can be used as a phenotypic character, and
hence a potential source of defining limb identity, these findings
suggest that these hindlimb up-regulated transcription factors are
likely to play key roles in repressing the expression of forelimb
specific genes in the hindlimb. Hoxc10 was identified as the gene
with the second highest expression level in the hindlimb, relative to
forelimb, and its close relative Hoxc9 was ranked 7
th. Despite the
fact that these two genes have displayed no hindlimb phenotypes
in loss of function mice [24,25], the dramatic up-regulation of
these two genes in the hindlimb may suggest that these two
homeobox transcription factors may have a yet not fully
appreciated role in contributing to limb identity, in the mouse.
While it is still unclear what genetic components are required
for specifying the identity of limbs to distinguish features unique to
hands and feet, our data creates new opportunities to expand our
current views, by comprehensively distinguishing genes that have
restricted expression patterns, or are quantitatively distinct
between fore- and hind-limbs. An alternative possibility to the
bauplan hypothesis proposed where the forelimb represents the
default genetic plan, and the hindlimb is primarily mediated by
Pitx1/Tbx4 is that limb identify represents the sum of both
quantitative and qualitative shifts in expression patterns that
ultimately give rise to bones that are different shapes and sizes,
along with the accompanying muscle/vasculature/nerve architec-
ture. While we only find 11 transcripts to be enriched more than
.2 fold in the hindlimb we actually observe a much larger number
of genes that are significantly more highly expressed in the
hindlimb at E10.5 than in the forelimb (Figure 7B), but at less than
a 2-fold threshold. Unfortunately, because the hindlimb has a
slight developmental delay of almost half a day, it is very hard to
determine what genes expressed in the E9.5 forelimb overlap with
an equivalent developmental stage in the hindlimb, and we have
yet to determine which of these transcripts are truly differentially
expressed, or represent a slight developmental delay.
A recent report examining digit identity in chicken identified
Socs2 as a transcript highly expressed specifically in the third wing
digit, but excluded in all other forelimb and hindlimb digits. This
gene was also identified by our study as one of the most enriched
forelimb specific gene, uniquely up-regulated in the E12.5
forelimb-hindlimb comparison, suggesting that this transcript
may be involved in specifying forelimb digit identity, in mice
and chickens [26]. The findings by Wang et al suggest that further
functional characterization of the novel genes we found to be up-
regulated in the forelimb are likely to emerge as contributors for
morphological genetic programs. One other possibility that has
not yet been explored and may account for morphological
differences in limb and digit identity is gene repression via micro
RNAs (miRNA). Recently, it has been shown that miRNAs can
determine cell fate. In particular Yoo et al were able to change the
fate of human fibroblasts into neurons through the overexpression
of a particular set of miRNAs. It is therefore plausible that
hindlimb identify may be driven by a miRNA down-regulation of
forelimb specific genes. While this is still a hypothesis, future
characterization of miRNA profiles during limb development will
be able to confirm if regulatory RNAs play a significant role in
limb morphogenesis.
Candidate Genes for Limb Defects in Humans
Our work was primarily motivated by the disconnect between
the number of syndromes accompanied by hand and digit
malformation which exceeds the number of confirmed genes
associated with these syndromes by more than 4 fold (84 genes
confirmed to cause congenital limb defects/341 syndromes with
hand/digit defects). The work herein offers the opportunity to
shed light on the genetic basis for some of these well documented
limb defects that sometimes occur with significant frequency. With
the advancement of highly quantitative platforms for gene
expression analysis that gives raw counts of mRNA, one could
envision the generation of a limb-specific array representing a
large percentage of transcripts enriched in the limb that can be
tested on limb derived RNA from ENU derived mutant mice that
display limb defects. Such a platform would expedite mapping of
candidate genes to their physical location in the mouse genome.
Alternatively, one can envision a genotyping platform that allows
patients with congenital hand/foot defect to be tested for
candidate mutations in these genes. In general finding transcrip-
tional differences between healthy and diseased or malformed




Approvals for work conducted on the mice used in this study
were granted by Lawrence Livermore National Laboratory
Institutional Animal Care and Use Committee, under application
no. 168. Animals were treated humanely; housing and experi-
mental procedures followed the guidelines outlined in the National
Institute of Health ‘Principles of Laboratory Care’.
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Wildtype mice (FVB) were used as the tissue source for the
microarray analysis. Embryonic day 0.5 (E0.5) was established at
noon the day a plug was identified. Pregnant females were
euthanized by CO2 followed by cervical dislocation, and harvested
embryos were dissected under a dissecting scope in ice cold
RNase-free phosphate buffered saline (PBS). Embryos were staged
according to Wanek at al. (1989) [27]. For each sample fore- or
hind-limb buds were from one embryo only, from a total of 5
embryos. All analyzed embryos are experimental replicates and
originate from one mouse plug. Total RNA was isolated using
Qiagen Rnasy, per manufacturer’s suggestions.
QC and Microarray Hybridization
Microarray expression analysis was performed using Affyme-
trixH Mouse GeneChips 430 2 (430v2). Hybridization of biotin-
labeled cRNA fragment to Mouse Genome 430 2.0 array,
washing, staining with streptavidin-phycoerythrin (Molecular
Probes), and signal-amplification were performed according to
the manufacturer’s instructions.
Microarray Preprocessing and Identification of
Differentially Expressed Genes
Fifty-two array data sets were analyzed to search for genes with
expression levels significantly altered between different time points
and between fore- and hind-limb. For each time point, up to 5
biological replicates were obtained from the same litter for each
limb, and 2 from whole embryos. Each sample represents the total
RNA collected for fore-, hind-limbs, and whole-embryo homog-
enates from single embryos, for up to 12 arrays per time point.
Mouse Genome 430 2.0 arrays contain 45,101 probe sets
associated with ,20,000 genes. Probe sets were mapped to genes
using information provided by the Jackson Laboratory (http://
www.informatics.jax.org/). Compared to the whole embryo
controls, we identified 6216 differentially expressed genes. All
data is MIAME compliant and the raw data has been deposited in
a MIAME compliant database (GSE30138).
All analyses were performed using R [28], BioConductor [29],
and several customized Perl scripts. R packages ‘‘affy’’ [30] and
‘‘simpleaffy’’ [31] and ‘‘affyQCReport’’ [32] were employed to
evaluate the quality of the arrays by means of images, histograms,
box plots, degradation plots, and scatter plots. CEL files were
scrutinized for spatial artifacts using Harshlight package
(PMC1274260). Using the median value of a group of replicates
as the reference value, we corrected a small blemish affecting the
readings for one of the whole-embryo control samples at E12.5.
Expression values were derived using the Robust Multichip
Average (RMA) protocol [33] with default settings. All analyses
were done at the so-called sequence level, i.e., data from probes
representing the same gene were combined. We did not apply any
unspecific filter on the expression values. Differentially expressed
genes were identified using an empirical Bayes method imple-
mented in the R package ‘‘Limma’’ [34]. P-values were corrected
for multiple testing using a 5% false discovery rate [35]. The
expression fold change (FC) of a gene was calculated as the ratio
between its average normalized expression value in a given limb
sample and in the time-matched control. Therefore, a fold change
of 1 (log2 FC=0) indicates no change, while a fold change of 2
(log2 FC=1) equals a doubling in transcript abundance, and a fold
change of 0.5 represents a reduction by half (log2 FC=21).Genes
with expression fold-changes of 2 or greater with adjusted p-
value,0.001 were considered differentially expressed.
Top Up-regulated Forelimb Genes
Genes that were differentially expressed (i.e., displayed a fold-
change of 2 or greater, with an adjusted p-value,0.001) between
fore-limb samples and time-matched controls were sorted by
decreasing fold change values.
Clustering Analysis
We sorted the 3215 genes up-regulated with respect to controls
at least at one fore-limb developmental stage based on expression
fold change similarity. For this purpose, at each developmental
stage, genes were classified into either up-regulated or down-
regulated/unchanged, and separated into the 31 non-overlapping
clusters representing all possible combinations of expression
patterns at 5 different forelimb developmental stages. For instance,
cluster 1 (Figure 4A) comprises genes up-regulated in forelimb at
time 9.5, and down-regulated/unchanged at all other considered
time points.
Functional analysis
Functional analysis was based on over-representation of GO
terms (PMCID: PMC3013640). Statistical enrichment of GO
terms was quantified by using the hypergeometric distribution
statistics. We report categories with p-values adjusted for multiple
testing using Benjamini and Hochberg’s method [35] that are
smaller than 0.05.
Limb identity
Since hindlimb development is delayed by an approximate half
a day, to account for transcriptional changed due to this
forelimb/hindlimb developmental discrepancy, we defined fore-
limb specific genes as genes that are up-regulated in forelimbs
with respect to time matched controls (i.e., displayed a fold-
change of 2 or greater, with an adjusted p-value,0.001) at a
particular developmental stage, and not up-regulated in hind-
limbs within the same stage, as well as in the subsequent
developmental stage. Similarly, we defined hind-limb specific
genes as genes that are up-regulated in hindlimb at a given
developmental stage with respect to time matched controls, and
not up-regulated in forelimbs within the same stage, as well as in
the preceding developmental stage.
Whole Mount In situ Hybridization (WISH)
WISH was performed as previously described [36] with some
modifications. Briefly, embryos were isolated from timed preg-
nancies of C57BL6 mice (Jackson Labs) and fixed overnight at 4uC
in 4%PFA in PBS and stored in 100% Methanol at 220uC until
ready to use. Embryos were rehydrated gradually into PBT, and
endogenous peroxidase quenched with 6% H2O2 in PBT for one
hour. Hybridization was performed with digoxigenin labeled
antisense riboprobes for 16 hrs at 70uC. Post-incubation the
embryos were washed in 50% formamide, 4X SSC, 1% SDS and
50% Formamide, 2XSSC for one hour each at 65uC. After
blocking embryos (2% Roche Blocking agent in 1XMAB) for 1 hr,
embryos were incubated overnight at 4uC in 1:3000 anti-
digoxigenin AP Fab fragment antibody. Color was developed
with BM Purple. For probe info see Material and Methods S1.
Supporting Information
Figure S1 Known Genes Identified among the Top 100
Up-regulated Genes. 279 genes were examined for their
putative protein function, available in situ expression in the limb,
and description of null mouse phenotype. Here are some in situ
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PLoS ONE | www.plosone.org 15 December 2011 | Volume 6 | Issue 12 | e28358expression patterns for the genes known to function during limb
development. *LacZ expression pattern of the knock-in allele.
(TIF)
Figure S2 Whole Embryo and Limb Average Expression
Values. Whole embryo expression values are independent of
whether a gene is up-regulated or not in the limb (P-
value=0.4610213, Wilcoxon rank sum test). Solid lines
represent expression distribution for limb and dashed lines for
whole embryo [all (green); up-regulated in limb (black); not up-
regulated (red)].
(TIF)
Figure S3 Whole Embryo and Limb Normalized Log2
Expression Values for Oscillating Genes. The log2
expression values were normalized for each gene such that the
mean and standard deviation across all arrays are 0 and 1,
respectively. The height of the bar represents the average of this
normalized expression value for each sample. Whole embryo
expression is visualized by black bars and limb expression by red
bars. Each cluster (A) On E10.5, E12.5; (B) On E10.5, E13.5; (C)
On E9.5, E11.5; (D) Off E9.5, E11.5; (E) Off E12.5, has whole
embryo values below 0 (except for E13.5 in panel C), suggesting
that whole embryo expression is very low relative to limb
expression which is dominantly above 0.
(TIF)
Table S1 Top 100 upregulated genes.
(PDF)
Table S2 Expression values for genes known to function
during limb development, or family members of signal
transduction pathways known to contribute to limb
patterning.
(PDF)
Table S3 Clusters of Differential Gene Expression.
(PDF)
Table S4 Stage-specific enriched genes.
(PDF)
Table S5 Forelimb and Hindlimb up-regulated tran-
scripts.
(XLSX)
Material and Methods S1 In Situ Probe Information.
(PDF)
References S1 Supplemental references.
(PDF)
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